John F. Neylan - Sep 20, 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Senior Vice President and Chief Medical Officer
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for John F. Neylan
Stock symbol
ELTX
Transactions as of
Sep 20, 2021
Transactions value $
-$3,786
Form type
4
Date filed
9/21/2021, 04:32 PM
Previous filing
Aug 19, 2021
Next filing
Oct 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Sale -$3.79K -376 -1.03% $10.07 36.2K Sep 20, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.07 to $10.09 inclusive.

Remarks:

Senior Vice President and Chief Medical Officer